Abstract
Summary
Andro-stanazole (17β-hydroxy-17α-methylandrostano[3,2-c] pyrazole) has been evaluated for its nitrogen-retaining and androgenic activities in castrated male rats. Orally, it appears to be 30 times more anabolic and 1/4 as androgenic as methyl-testosterone. Parenterally, it appears to be 1/20 as anabolic and 1/40 as androgenic as testosterone propionate. Andro-stanazole is clearly an agent which merits further investigation for oral administration to patients under conditions where maximum anabolic action with minimum androgenic side effects is desired.
Get full access to this article
View all access options for this article.